Pediatric Blood & Cancer

Papers
(The H4-Index of Pediatric Blood & Cancer is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
83
49
42
42
Feasibility of indocyanine green‐guided localization of pulmonary nodules in children with solid tumors39
Children's Oncology Group 2023 blueprint for research: Cancer care delivery research38
The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis38
Psychosexual functioning in cancer survivorship: What the pediatric oncologist needs to know36
Efficacy of dual‐task training on stability and function in children with ataxia after medulloblastoma resection: A randomized controlled trial35
After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?33
Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma33
Bloodletting as Medical Child Abuse Revealed by Lack of Iron Accumulation Despite Multiple Erythrocyte Transfusions28
Impact of Food Insecurity on Malnutrition Treatment Response in Nigerian Children With Sickle Cell Anemia and Severe Acute Malnutrition27
The Ukrainian children emergency: How the Pediatric Oncology Unit of Turin supports cancer patients and their families who have escaped war26
Global nLPHL One Working Group (GLOW) Research Roadmap for Nodular Lymphocyte‐Predominant Hodgkin Lymphoma26
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors25
Fatal brainstem injury following proton radiation in a patient with medulloblastoma and a germline variant in RNF21325
Strategies for the Treatment of Desmoplastic Small Round Cell Tumor: A Case Series25
Bone mineral density in primarily preadolescent children with hemoglobin E/β‐thalassemia with different severities and transfusion requirements25
Mini‐hyper CVD + CRIB (condensed rituximab, inotuzumab ozogamicin, and blinatumomab) for refractory pediatric B‐acute lymphoblastic leukemia24
Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma‐derived von Willebrand factor24
Feasibility of treating pediatric intracranial germ cell tumors in a middle‐income country: The Jordanian experience23
Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort23
Metastatic and multiply relapsed SDH‐deficient GIST and paraganglioma displays clinical response to combined poly ADP‐ribose polymerase inhibition and temozolomide23
0.064162015914917